Giessen, Germany

Mehmet Kemal Tur


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Koln, DE (2015)
  • Aachen, DE (2013 - 2018)
  • Giessen, DE (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mehmet Kemal Tur: Innovator in Cancer Treatment

Introduction

Mehmet Kemal Tur is a prominent inventor based in Giessen, Germany. He has made significant contributions to the field of cancer treatment, particularly in targeting acute myeloid leukemia (AML) cells. With a total of 4 patents to his name, Tur's work is paving the way for innovative therapies in oncology.

Latest Patents

Among his latest patents is a fusion protein designed to target and treat acute myeloid leukemia cells. This polypeptide binds to the surface of AML blast cells and is internalized upon binding, offering a novel approach to treatment. Additionally, he has developed photoimmunoconjugates for use in photodynamic therapy, which comprise compounds that enhance the effectiveness of light-based treatments for cancer.

Career Highlights

Throughout his career, Tur has worked with esteemed organizations such as the Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. and the Rheinisch-Westfälische Technische Hochschule Aachen. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Tur has collaborated with notable colleagues, including Stefan Barth and Jenny Fitting. Their combined expertise has contributed to the advancement of innovative solutions in cancer therapy.

Conclusion

Mehmet Kemal Tur's work exemplifies the impact of innovation in medical science, particularly in the fight against cancer. His patents and collaborations highlight his commitment to improving treatment options for patients with acute myeloid leukemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…